About Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes
During the past decade, Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes
According to Clinical.Site data, the most researched conditions in "Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes" are
"Infective Endocarditis" (2 trials). Many other conditions were trialed in "Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes" in a lesser frequency.
Clinical Trials Intervention Types at Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes
Most popular intervention types in "Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Amoxicillin" (1 trials), "Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine" (1 trials), "Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin" (1 trials), "Levofloxacin" (1 trials) and "Rifampicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes
The vast majority of trials in "Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes" are
2 trials for "All" genders.
Clinical Trials Status at Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes
Currently, there are NaN active trials in "Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Service de Maladies infectieuses et tropicales, Hôpital Hôtel Dieu, CHU Nantes, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".